|
Market Research Report
Diagnostic and Therapeutic Trends in Alzheimer's Disease
|
Diagnostic and Therapeutic Trends in Alzheimer's Disease published by Technical Insights, Inc. in June, 2008. This report price starts from US $ 6500.
Abstract
This research service analyses the latest diagnostic and therapeutic
developments that have occurred in the Alzheimer' s disease sector, both from a
technology and industry perspective.
Table of Contents
1. EXECUTIVE SUMMARY
Research Scope and Methodology
- Research Scope
- Research Methodology
Research Highlights
- Industry Overview and Key Trends
- Snapshot of Noteworthy Developments
2. TECHNOLOGY PRIMER
Alzheimer' s Disease (AD) Overview
- AD--A Century Old Pathology
- Theories in AD--The Role of Plaques and Tangles
- Disease Stages; Symptoms; and Statistics
Alzheimer' s Disease Diagnosis and Therapy Overview
- Diagnosis of AD
- Therapy Overview
3. TECHNOLOGY INTELLIGENCE IN THE AD SPACE
Novel Mechanism of Action Drugs--Corporate Advancements
- A ‘Food Drug' a Day May Keep Alzheimer' s disease Away
- Protecting Neurons by Targeting Cells' Powerhouses
- Novel Neuroprotective Therapeutic Agents May Soon Validate ' Tau Theory' in
Alzheimer' s
- Steroids Mediated Clearance of Amyloid Plaques in Alzheimer' s
- Improving Memory by Amplifying a Novel Receptor Implicated in
Neurotransmission
- A Broad Portfolio of Novel Drugs in the Pipeline for Alzheimer' s
AD Therapeutics--Academic Research Highlights
- Study Identifies Molecule Involved in Beta-Amyloid Induced Neuron Death
- Vaccine for Alzheimer' s Triggers a Safe Immune Response and Clears Amyloid
Plaques in a Mice Study
Advances in AD Diagnosis--Corporate and Academic Efforts
- Alzheimer' s Diagnosis Made Simple and Safe with a Novel Blood Test
- Advances in In Vitro Detection of the Amyloid Plaques in Alzheimer' s
- Computers to the Rescue - A Novel Approach to Early AD Diagnosis
- Imaging Studies Reveal a Functional Maker Implicated in Early Alzheimer' s
Disease
4. TECHNOLOGY ADOPTION FACTOR ANALYSIS
Force-Field Analysis
- The Driving Forces
- The Restraining Forces and Challenges
Strategic Evaluation of the Competitive Environment
- A Strategic Evaluation of AD Medication Space--SWOT Analysis
- Strategic Assessment of Competitive Landscape and Attractiveness of AD
Therapeutics Sector--World
Current and FutureTrends; Industry Roadmap; and Strategic Recommendations (Analyst' s Perspectives)
- Roadmap of Diagnostic and Therapeutic Trends in AD Sector
- Strategic Recommendations for Existing Symptomatic Drugs
- Strategic Recommendations for Disease Modifying Drugs
5. INTELLECTUAL PROPERTY (IP) SCENARIO; KEY CONTACTS
The IP Scenario
- Alzheimer' s Disease Therapeutics--Key Patents
- Alzheimer' s Disease Diagnostics--Key Patents
Key Contacts
- Key Corporate Contacts
- Key Academic Contacts
6. DECISION SUPPORT DATABASE TABLES
Database Tables
- Total Healthcare Expenditure--World (2002 to 2012)
- Pharmaceutical R&D Expenditure--World (2002 to 2012)
- Number of Physicians--World (2002 to 2012)
- Number of Hospitals--World (2002 to 2012)
- Number of Nurses--World (2002 to 2012)
|
